In addition, elevated GSK-3β activity is also associated with Alzheimer’s disease and there is a direct link with hyperphosphorylation of DRP2 at GSK-3β-dependent phosphorylation sites and increased amyloid precursor protein [37,39,45]. Here, APP is linked to early-onset autosomal dominant Alzheimer disease.